TDAC CEO Buys Low‑Cost Warrants, Boosting Confidence in ProLogium Merger
TDAC CEO buys 53k warrants at $0.79, backing its ProLogium merger—insider confidence, low cost, and future upside for investors.
3 minutes to read
Translational Development Acquisition Corp